Aviragen Therapeutics - M&A Summary and Business Overview

Life ScienceCompany

Aviragen Therapeutics M&A Summary

Aviragen Therapeutics has acquired 2 companies.

Aviragen Therapeutics’ largest acquisition to date was in 2012, when it acquired Nabi Biopharmaceuticals for $100M. Aviragen Therapeutics has acquired in 1 US state, and 2 countries. The Company’s most targeted sectors include life science (100%).

Aviragen Therapeutics Business Overview

Where is Aviragen Therapeutics headquartered?

Aviragen Therapeutics is headquartered in Alpharetta, Georgia.

How many employees does Aviragen Therapeutics have?

Aviragen Therapeutics has 19 employees.

What sector is Aviragen Therapeutics in?

Aviragen Therapeutics is a life science company.

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity2
  • Total Sectors Invested 1
  • Total Countries Invested 2
  • M&A Advisors 1

Aviragen Therapeutics, Inc.

2500 Northwinds Parkway,
Alpharetta, Georgia 30009
United States,
(678) 221-3343
www.aviragentherapeutics.com

Aviragen Therapeutics, Inc. is a developer of innovative products for the prevention and treatment of serious and potentially life-threatening infectious diseases.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 2 - - - - - 2
vol $100M $100M
Sell (0.0/yr) # - - - - - - 0
  2

Most Recent M&A

Company Date Value Type
Anaconda Pharma SAS 2015-06-03 - Add-on Acquisition
Paris, France
Nabi Biopharmaceuticals, Inc. 2012-10-30 100M USD Add-on Acquisition
Rockville, Maryland · www.nabi.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 2 (100%) 100M (100%) - -
Total 2 $100M - -

By Geo

State/Country Buy Value Sell Value
France 1 - - -
United States 1 100M - -
  Maryland 1 100M - -
Domestic 1 (50%) 100M (100%) - -
Cross-border 1 (50%) - - -
Total 2 $100M - -

Top M&A Advisors

Financial Deals
Stonebridge Associates LLC
1

Deal Values

buy # Total
< $100M 1 $100M
TOTAL $100M
Largest Nabi Biopharmaceuticals, Inc.
$100M (2012-10-30)

 Subscribe to unlock this and 209,130
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.